These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31338174)
21. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia. Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134 [TBL] [Abstract][Full Text] [Related]
22. Hereditary haemorrhagic telangiectasia in a black adult male: case report. Kitonyi GW; Wambugu PM; Oburra HO; Ireri JM East Afr Med J; 2008 Aug; 85(8):412-6. PubMed ID: 19115559 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis. Karnezis TT; Davidson TM Laryngoscope; 2011 Mar; 121(3):636-8. PubMed ID: 21344445 [TBL] [Abstract][Full Text] [Related]
24. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Vaiman M; Martinovich U; Eviatar E; Kessler A; Segal S Blood Coagul Fibrinolysis; 2004 Jun; 15(4):359-63. PubMed ID: 15166924 [TBL] [Abstract][Full Text] [Related]
25. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia. Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959 [TBL] [Abstract][Full Text] [Related]
26. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report]. Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024 [TBL] [Abstract][Full Text] [Related]
27. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912 [TBL] [Abstract][Full Text] [Related]
28. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia. Parambil JG; Woodard TD; Koc ON Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965 [TBL] [Abstract][Full Text] [Related]
29. Hereditary Hemorrhagic Telangiectasia: A Rare Cause of Anemia. Jan W; Tameez Ud Din A; Chaudhary FMD; Tameez-Ud-Din A; Nawaz F Cureus; 2019 Aug; 11(8):e5349. PubMed ID: 31602353 [TBL] [Abstract][Full Text] [Related]
36. Hereditary HaemorrhagicTelangiectasia--A Rare Cause of Severe Anaemia. Deshpande P; Bhat S; Karmarkar A J Assoc Physicians India; 2014 Dec; 62(12):48-51. PubMed ID: 26259423 [TBL] [Abstract][Full Text] [Related]
37. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613 [TBL] [Abstract][Full Text] [Related]
38. Bevacizumab as rescue treatment for severe recurrent gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. Lupu A; Stefanescu C; Treton X; Attar A; Corcos O; Bouhnik Y J Clin Gastroenterol; 2013 Mar; 47(3):256-7. PubMed ID: 23164683 [TBL] [Abstract][Full Text] [Related]
39. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia. Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219 [TBL] [Abstract][Full Text] [Related]
40. A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report. Khan AR; Waqar S; Wazir MH; Arif A Cureus; 2022 Apr; 14(4):e24517. PubMed ID: 35651452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]